ViewRay

ViewRay Gross Profit

The Gross Profit of ViewRay (VRAYQ) as of Oct 19, 2026 is 10.05 M USD. In the previous year, Gross Profit was 335,000.00 USD — a change of 2,898.51% (higher).

Gross Profit

10.05 MUSD

YoY

2,898.51%

Last updated:

Gross Profit of ViewRay is 2022 10.05 M USD. Gross Profit of ViewRay was 2021 335,000.00 USD. It decreases by 2,898.51% higher compared to the previous year.

The ViewRay Gross Profit history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Profit
Date
Gross Profit
Jan 1, 2015
-4.15 M USD
Jan 1, 2016
-3.63 M USD
Jan 1, 2017
6.33 M USD
Jan 1, 2018
6.60 M USD
Jan 1, 2019
-5.48 M USD
Jan 1, 2020
-4.06 M USD
Jan 1, 2021
335,000.00 USD
Jan 1, 2022
10.05 M USD
The ViewRay Gross Profit history
YEARGross ProfitYoY
10.05 MUSD+2,898.51%
335,000.00USD-108.25%
-4.06 MUSD-25.90%
-5.48 MUSD-182.96%
6.60 MUSD+4.28%
6.33 MUSD-274.48%
-3.63 MUSD-12.64%
-4.15 MUSD+48.36%
-2.80 MUSD-44.31%
-5.03 MUSD+170.32%
-1.86 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ViewRay Revenue

ViewRay Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
87.78 M USD
-120.80 M USD
-120.20 M USD
Jan 1, 2020
57.02 M USD
-105.39 M USD
-107.91 M USD
Jan 1, 2021
70.12 M USD
-105.82 M USD
-110.05 M USD
Jan 1, 2022
102.21 M USD
-103.96 M USD
-107.33 M USD
Jan 1, 2023 (e)
0.00 USD
-100.12 M USD
0.00 USD
Jan 1, 2024 (e)
0.00 USD
-86.42 M USD
0.00 USD
Jan 1, 2025 (e)
121.78 M USD
-118.11 M USD
-53.20 M USD
Jan 1, 2026 (e)
306.40 M USD
-297.17 M USD
-11.00 M USD

ViewRay Margins

ViewRay stock margins

The ViewRay margin analysis displays the gross margin, EBIT margin, as well as the profit margin of ViewRay. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for ViewRay.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
-6.24 %
-137.61 %
-136.93 %
Jan 1, 2020
-7.12 %
-184.84 %
-189.26 %
Jan 1, 2021
0.48 %
-150.91 %
-156.94 %
Jan 1, 2022
9.83 %
-101.72 %
-105.01 %
Jan 1, 2023 (e)
9.83 %
- %
0.00 %
Jan 1, 2024 (e)
9.83 %
- %
0.00 %
Jan 1, 2025 (e)
9.83 %
-96.99 %
-43.69 %
Jan 1, 2026 (e)
9.83 %
-96.99 %
-3.59 %

ViewRay Stock analysis

What does ViewRay do? ViewRay Inc. is an American medical technology company based in Cleveland, Ohio. It was founded in 2004 by Ivor Jankovic and specializes in the manufacturing of radiation therapy devices. The history of ViewRay begins with the idea of developing innovative technology to treat cancer patients more effectively and gently. In 2005, the company entered into an agreement with the Cleveland Clinic Lerner Research Institute to conduct research on a novel magnetic resonance-guided radiation therapy machine. The research project was led by James F. Dempsey, Chair of the Department of Radiation Oncology at the Cleveland Clinic. In 2009, the first magnetic resonance-guided radiation therapy system was delivered and implemented at the Cleveland Clinic. ViewRay's business model is based on the development and manufacturing of innovative medical devices aimed at making the treatment of cancer patients more effective and gentle. The company focuses on combining magnetic resonance imaging (MRI) and radiation therapy to ensure more precise and safer treatment. ViewRay offers various products, including the MRIdian-Linac system, an advanced radiation therapy device that utilizes MRI technology to provide real-time images of the tumor during radiation. This allows for precise targeting of the tumor while sparing the surrounding tissue. The system also offers the ability to sync radiation therapy with the patient's breathing cycle, further improving the accuracy and effectiveness of the treatment. In addition to the MRIdian-Linac system, ViewRay also offers the MRIdian-MRI system, which is solely dedicated to imaging. The MRIdian-MRI is a diagnostic instrument that allows for better visualization of tissue and tumor studies. The system uses the same MRI technology as the MRIdian-Linac to generate radiation-free images. ViewRay has also specialized in the development of software tools that assist doctors in better planning and monitoring radiation therapy. This includes the RayCare Oncology Information System, which provides a comprehensive workflow and management platform, as well as the RayStation Treatment Planning Software, which enables more precise radiation therapy planning. In terms of market reach, ViewRay has a global presence. The company has a strong presence in North America, Europe, and Asia, and works closely with leading research institutes and hospitals to evaluate and improve the effectiveness and efficiency of its technologies. Overall, ViewRay has developed an innovative and unique portfolio of products and solutions that improve radiation therapy and increase accuracy and safety for patients and doctors. The company is a leader in the development of MRI-guided radiation therapy systems and is expected to continue playing a significant role in the medical technology industry in the future. ViewRay is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ViewRay stock

Gross Profit of ViewRay is 10.05 M USD in 2022.

Gross Profit of ViewRay changed from 335,000.00 USD to 10.05 M USD, representing a 2,898.51% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Profit ViewRay since 2006 – with annual values, charts, and detailed analysis.

Gross Profit is the revenue remaining after deducting the cost of goods sold. It shows how efficiently a company uses its resources to produce goods or services.

Gross Profit's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Gross Profit's ViewRay historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — ViewRay

All Key Metrics — ViewRay